Selinexor in patients with advanced and recurrent endometrial cancer

Bogani, G; Monk, BJ; Coleman, RL; Vergote, I; Oakin, A; Ray-Coquard, I; Mariani, A; Scambia, G; Raspagliesi, F; Bolognese, B

Bogani, G (通讯作者),Fdn IRCCS Ist Nazl Tumori Milano, I-20133 Milan, Italy.

CURRENT PROBLEMS IN CANCER, 2023; 47 (6):

Abstract

Selinexor is an oral inhibitor of the nuclear export protein called Exportin 1 (XPO1) with demonstrated an-titumor activity in hematological and solid......

Full Text Link